Literature DB >> 12010869

Primary biliary cirrhosis: seeking the silent partner of autoimmunity.

I Sutton1, J Neuberger.   

Abstract

Primary biliary cirrhosis is a disorder characterised by an intense inflammatory response in the septal and interlobular bile ducts and is considered to be an autoimmune disease. Evidence to suggest that chronic viral infection could be a crucial element in the development of biliary epithelial cell damage and activation of the associated autoimmune response is reviewed

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 12010869      PMCID: PMC1773250          DOI: 10.1136/gut.50.6.743

Source DB:  PubMed          Journal:  Gut        ISSN: 0017-5749            Impact factor:   23.059


  30 in total

1.  Autoimmune diseases: genes, bugs and failed regulation.

Authors:  J Ermann; C G Fathman
Journal:  Nat Immunol       Date:  2001-09       Impact factor: 25.606

Review 2.  Drug-induced cholestasis.

Authors:  S Chitturi; G C Farrell
Journal:  Semin Gastrointest Dis       Date:  2001-04

3.  Natural history of early primary biliary cirrhosis.

Authors:  J V Metcalf; H C Mitchison; J M Palmer; D E Jones; M F Bassendine; O F James
Journal:  Lancet       Date:  1996-11-23       Impact factor: 79.321

Review 4.  PBC and AMA--what is the connection?

Authors:  J Neuberger; R Thomson
Journal:  Hepatology       Date:  1999-01       Impact factor: 17.425

5.  Shaping of the autoreactive T-cell repertoire by a splice variant of self protein expressed in thymic epithelial cells.

Authors:  L Klein; M Klugmann; K A Nave; V K Tuohy; B Kyewski
Journal:  Nat Med       Date:  2000-01       Impact factor: 53.440

6.  Enzyme inhibitory autoantibodies to pyruvate dehydrogenase complex in primary biliary cirrhosis: applications of a semiautomated assay.

Authors:  K L Teoh; M J Rowley; H Zafirakis; E R Dickson; R H Wiesner; M E Gershwin; I R MacKay
Journal:  Hepatology       Date:  1994-11       Impact factor: 17.425

7.  Primary biliary cirrhosis. High proportions of B cells in blood and liver tissue produce anti-mitochondrial antibodies of several Ig classes.

Authors:  A Björkland; L Lööf; I Mendel-Hartvig; T H Tötterman
Journal:  J Immunol       Date:  1994-09-15       Impact factor: 5.422

8.  Heterogeneity of combinatorial human autoantibodies against PDC-E2 and biliary epithelial cells in patients with primary biliary cirrhosis.

Authors:  S Cha; P S Leung; R L Coppel; J Van de Water; A A Ansari; M E Gershwin
Journal:  Hepatology       Date:  1994-09       Impact factor: 17.425

9.  Autoreactive CD8+ T-cell responses to human myelin protein-derived peptides.

Authors:  T Tsuchida; K C Parker; R V Turner; H F McFarland; J E Coligan; W E Biddison
Journal:  Proc Natl Acad Sci U S A       Date:  1994-11-08       Impact factor: 11.205

10.  High frequency of autoreactive myelin proteolipid protein-specific T cells in the periphery of naive mice: mechanisms of selection of the self-reactive repertoire.

Authors:  A C Anderson; L B Nicholson; K L Legge; V Turchin; H Zaghouani; V K Kuchroo
Journal:  J Exp Med       Date:  2000-03-06       Impact factor: 14.307

View more
  5 in total

Review 1.  Primary biliary cirrhosis: From bench to bedside.

Authors:  Elias Kouroumalis; George Notas
Journal:  World J Gastrointest Pharmacol Ther       Date:  2015-08-06

Review 2.  Primary biliary cirrhosis: Clinical and laboratory criteria for its diagnosis.

Authors:  Vasiliy Ivanovich Reshetnyak
Journal:  World J Gastroenterol       Date:  2015-07-07       Impact factor: 5.742

Review 3.  Primary biliary cirrhosis: what do autoantibodies tell us?

Authors:  Chao-Jun Hu; Feng-Chun Zhang; Yong-Zhe Li; Xuan Zhang
Journal:  World J Gastroenterol       Date:  2010-08-07       Impact factor: 5.742

Review 4.  Pathogenesis of primary biliary cirrhosis: a unifying model.

Authors:  Elias Kouroumalis; George Notas
Journal:  World J Gastroenterol       Date:  2006-04-21       Impact factor: 5.742

Review 5.  Concept on the pathogenesis and treatment of primary biliary cirrhosis.

Authors:  Vasiliy-Ivanovich Reshetnyak
Journal:  World J Gastroenterol       Date:  2006-12-07       Impact factor: 5.742

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.